Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX0VUZ
|
||||
Drug Name |
(R)-3-(1H-Indol-3-yl)-N,N-dipentyl-2-(3-p-tolyl-ureido)-propionamide
|
||||
Synonyms |
CHEMBL326979
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C29H40N4O2
|
||||
Canonical SMILES |
CCCCCN(CCCCC)C(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)Nc3ccc(C)cc3
|
||||
InChI |
InChI=1S/C29H40N4O2/c1-4-6-10-18-33(19-11-7-5-2)28(34)27(20-23-21-30-26-13-9-8-12-25(23)26)32-29(35)31-24-16-14-22(3)15-17-24/h8-9,12-17,21,27,30H,4-7,10-11,18-20H2,1-3H3,(H2,31,32,35)/t27-/m1/s1
|
||||
InChIKey |
XCPYSVOYIFJBJJ-HHHXNRCGSA-N
|
||||
Target and Pathway | |||||
Target(s) | Gastrin/cholecystokinin type B receptor | Target Info | [1587926] | ||
Cholecystokinin receptor type A | Target Info | [1587926] | |||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.